article thumbnail

How Data for ImmunoGen Drug Could the Way Doctors Treat Ovarian Cancer

MedCity News

In a confirmatory Phase 3 test of ImmunoGen’s Elahere, the ovarian cancer drug handily beat chemotherapy with results that clinicians say could make the treatment the new standard of care for certain patients. The data were presented during the annual meeting of the American Society of Clinical Oncology.

Doctors 240
article thumbnail

Free Prescription Drugs Are Often Available—If Only Your Doctor Can Find Them

MedCity News

Price transparency has come a long way over the past couple of years, with insurance companies and hospitals now required to publicly disclose their prices. The more pressing issue is that there is no mechanism in place to make this information easily digestible, personalized to each patient, and placed in context with competitors’ prices.

Doctors 241
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Online allergy startup raises $1.25M in pre-seed round

MedCity News

Based in San Francisco, Allermi aims to create a national market for a customizable approach to allergy relief pioneered by a California doctor.

Doctors 246
article thumbnail

The Journey to Personalized Healthcare

MedCity News

doctor visits, prescription pickups) and enriching our insights with the micro-moments surrounding these obvious events. The Walt Disney Company excels in designing exceptional service because they are hyper-focused on listening, tracking, designing, and measuring the experiences of guests visiting their properties.

article thumbnail

I Used AI Tech To Find My Own Cancer Clinical Trial, and You Can Too

MedCity News

My doctor ordered an MRI, which revealed a five-centimeter tumor on the right side, accompanied by lymph-node involvement. And, what else hasn’t my doctor told me about?” This was several weeks after my very first mammogram–which I underwent shortly after my 40th birthday–detected an anomaly on my left breast.

Doctors 317
article thumbnail

Amylyx wields axe as it pulls ALS drug from the market

pharmaphorum

The company said that it was stopping access to the drug for new patients immediately, while those already taking it would be able to continue on it via a free drug programme, after consultation with their doctors – a move that has garnered praise from across the biopharma industry.

article thumbnail

Fast-Tracking Development: How Life Sciences Will Drive Speed in 2025

PharmExec

Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed across product development with an emphasis on getting new treatments in the hands of doctors and patients.